Evidence map›Paper›PMID 30890191›Full record

ArticleJournal of the International Neuropsychological Society : JINS2019

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Rowan Saloner, Laura M Campbell, Vanessa Serrano, Jessica L Montoya, Elizabeth Pasipanodya, Emily W Paolillo, Donald Franklin, Ronald J Ellis, Scott L Letendre, Ann C Collier and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the International Neuropsychological Society : JINS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Correlates of SuperAging in Two Population-Based Samples of Hispanic Older Adults.The journals of gerontology. Series B, Psychological sciences and social sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. A mixed-methods exploration of faith, spirituality, and health program interest among older African Americans with HIV.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  17. Astrocytes, HIV and the Glymphatic System: A Disease of Disrupted Waste Management?Frontiers in cellular and infection microbiology · 2020
    Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Rowan Saloner1San Diego State University/University of California,San Diego Joint Doctoral Program in Clinical Psychology,San Diego,California.
Laura M Campbell1San Diego State University/University of California,San Diego Joint Doctoral Program in Clinical Psychology,San Diego,California.
Vanessa Serrano2Department of Psychiatry,University of California,San Diego,San Diego,California.
Jessica L Montoya2Department of Psychiatry,University of California,San Diego,San Diego,California.
Elizabeth Pasipanodya2Department of Psychiatry,University of California,San Diego,San Diego,California.
Emily W Paolillo1San Diego State University/University of California,San Diego Joint Doctoral Program in Clinical Psychology,San Diego,California.
Donald Franklin2Department of Psychiatry,University of California,San Diego,San Diego,California.
Ronald J Ellis2Department of Psychiatry,University of California,San Diego,San Diego,California.
Scott L Letendre3Department of Medicine,University of California,San Diego,San Diego,California.
Ann C Collier4Department of Medicine,University of Washington,Seattle,Washington.
David B Clifford5Department of Neurology,Washington University,St. Louis,Missouri.
Benjamin B Gelman6Department of Pathology,University of Texas Medical Branch,Galveston,Texas.
Christina M Marra7Department of Neurology,University of Washington,Seattle,Washington.
J Allen McCutchan3Department of Medicine,University of California,San Diego,San Diego,California.
Susan Morgello8Department of Neurology,Icahn School of Medicine of Mount Sinai,New York,New York.
Ned Sacktor9Department of Neurology,Johns Hopkins University School of Medicine,Baltimore,Maryland.
Dilip V Jeste2Department of Psychiatry,University of California,San Diego,San Diego,California.
Igor Grant2Department of Psychiatry,University of California,San Diego,San Diego,California.
Robert K Heaton2Department of Psychiatry,University of California,San Diego,San Diego,California.
David J Moore2Department of Psychiatry,University of California,San Diego,San Diego,California.
CHARTER and HNRP Groups

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NEUROAIDS TISSUE NETWORKR24MH059745 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 1998 to 2007
$13.2M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
Alcohol Research in the Science/Practitioner ModelT32AA013525 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI EDWARD P RILEY, ANDREA SPADONI TOWNSEND · 2002 to 2026
$8.4M
California NeuroAIDS Tissue Network (CNTN)U01MH083506 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2008 to 2012
$8.1M
Age related determinants of HAND: A 12 year follow-up of CHARTER participantsR01MH107345 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEATON, ROBERT KERNACHAN, LETENDRE, SCOTT L · 2015 to 2021
$7.9M
Training in Research on Addictions in Interdisciplinary NeuroAIDS (TRAIN)T32DA031098 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello, DAVID J MOORE · 2011 to 2026
$4.6M
Multi-Dimensional Successful Aging Among HIV-Infected AdultsR01MH099987 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JESTE, DILIP V., MOORE, DAVID J · 2013 to 2019
$3.8M
Midcareer Investigator Award in Patient-Oriented NeuroAIDS ResearchK24MH097673 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2013 to 2017
$917k
Using Ecological Momentary Assessment to Improve Self-Reported Cognitive Functioning among Adults with Comorbid HIV/AIDS and Heavy Alcohol UseF31AA027198 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PAOLILLO, EMILY · 2018 to 2019
$76k
CNS HIV ANTI-RETROVIRAL THERAPY EFFECTS RESEARCH /CHARTER/ -278022005-278022005N01MH022005 · NIMH · UNIVERSITY OF CA -SAN DIEGO · PI GRANT, IGOR · 2003 to 2006
–
NIAAA NIH HHS F31 AA027198NIAAA NIH HHS T32 AA013525NIDA NIH HHS T32 DA031098NIMH NIH HHS HHSN271201000030CNIMH NIH HHS HHSN271201000036CNIMH NIH HHS K24 MH097673NIMH NIH HHS N01 MH022005NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH099987NIMH NIH HHS R01 MH107345NIMH NIH HHS R24 MH059745NIMH NIH HHS U01 MH083506NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100930
6 · The paper itself

Abstract

objectivesStudies of neurocognitively elite older adults, termed SuperAgers, have identified clinical predictors and neurobiological indicators of resilience against age-related neurocognitive decline. Despite rising rates of older persons living with HIV (PLWH), SuperAging (SA) in PLWH remains undefined. We aimed to establish neuropsychological criteria for SA in PLWH and examined clinically relevant correlates of SA.

methods734 PLWH and 123 HIV-uninfected participants between 50 and 64 years of age underwent neuropsychological and neuromedical evaluations. SA was defined as demographically corrected (i.e., sex, race/ethnicity, education) global neurocognitive performance within normal range for 25-year-olds. Remaining participants were labeled cognitively normal (CN) or impaired (CI) based on actual age. Chi-square and analysis of variance tests examined HIV group differences on neurocognitive status and demographics. Within PLWH, neurocognitive status differences were tested on HIV disease characteristics, medical comorbidities, and everyday functioning. Multinomial logistic regression explored independent predictors of neurocognitive status.

resultsNeurocognitive status rates and demographic characteristics differed between PLWH (SA=17%; CN=38%; CI=45%) and HIV-uninfected participants (SA=35%; CN=55%; CI=11%). In PLWH, neurocognitive groups were comparable on demographic and HIV disease characteristics. Younger age, higher verbal IQ, absence of diabetes, fewer depressive symptoms, and lifetime cannabis use disorder increased likelihood of SA. SA reported increased independence in everyday functioning, employment, and health-related quality of life than non-SA.

conclusionsDespite combined neurological risk of aging and HIV, youthful neurocognitive performance is possible for older PLWH. SA relates to improved real-world functioning and may be better explained by cognitive reserve and maintenance of cardiometabolic and mental health than HIV disease severity. Future research investigating biomarker and lifestyle (e.g., physical activity) correlates of SA may help identify modifiable neuroprotective factors against HIV-related neurobiological aging. (JINS, 2019, 25, 507-519).

Indexed as

Activities of Daily LivingQuality of LifeCognitionCognitive AgingCognitive ReserveEmploymentFemaleHealthy LifestyleHIV InfectionsHumansMaleMarijuana UseMiddle AgedAcquired Immunodeficiency SyndromeCannabisCognitive declineCognitive reserveDiabetesNeuropsychology

Identifiers

PMID30890191
PMCPMC6705613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.